Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Teva Pharmaceutical Industries ( Cephalon )

ClinicalTrials.gov Identifier:

NCT01508936

First received: January 3, 2012

Last updated: March 19, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2013
Estimated Primary Completion Date:	September 2013 (Final data collection date for primary outcome measure)